He is the first paediatric patient with GNAO1 in Asia to undergo the procedure. Read more at straitstimes.com. Read more at ...

Initial blood work found hints of an infection, and the doctors initially suspected a bacterial skin infection (cellulitis) ...

AstraZeneca receives FDA approval for Koselugo to treat adults with NF1 and inoperable plexiform neurofibromas, backed by ...

An experiment on reptile decomposition aims to shed light on a variety of paleontological mysteries, including why so many ...

Sol-Gel intends to pursue high-frequency BCC as an additional indication for its lead drug candidate SGT-610, which, if approved, could at least ...

Researchers at the Perelman School of Medicine at the University of Pennsylvania report that adults with seborrheic ...

Clinicians must adapt to the new reality of HFMD, as emerging strains drive serious complications and challenge old ...

Another common feature: Patients with a number of autoimmune diseases, especially women, often suffer heart attacks and ...

A higher-titer ANA raises the suspicion that something more systemic may be going on,’ said Amanda Mixon, PA-C.

WAYNE, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella or “the Company”), a clinical-stage biopharmaceutical company focused on developing and ...

DSAP is a premalignant, progressive disease characterized by numerous expanding lesions which significantly impact quality-of-life; no FDA-approved therapies exist for the estimated more than 50,000 ...

Mona Shahriari, M.D., dermatologist at Central Connecticut Dermatology and an associate clinical professor at Yale School of Medicine discusses the highlights of her session called ‘Seeing Clearly: A ...